IP Library Granted Patent US 9,795,498
Granted Patent B2
US 9,795,498 · App. 14/433,752 · Granted Oct 24, 2017

Intragastric balloon for treating obesity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,795,498
App. No.
14/433,752
Granted
Oct 24, 2017
Kind
B2
Abstract

A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.

Claims (23)

1. An intragastric balloon configured to be implanted transorally into a patient's stomach to treat obesity, the intragastric balloon comprising:

an inflatable, closed, hollow, compliant body including an outer shell having an inner wall surrounding and defining a closed inner chamber, the closed inner chamber having a volume that is substantially the same both before and after the closed inner chamber is filled with a fluid,

wherein, in an implanted state, the closed inner chamber is filled partially with the fluids the body having a proximal end and a distal end opposite the proximal end, the shell being configured to retain the fluid in the closed inner chamber,

wherein the body is made of a material that permits the body to be compressed into a substantially linear transoral delivery configuration, and that will resist degradation over a period of at least six months within the stomach, and

wherein the closed inner chamber has one or more interconnected regions extending between the proximal and distal ends of the body, such that the fluid can flow freely within the closed inner chamber, the inflatable body filled with the fluid having a fluid volume that is less than the body volume, the body being constructed to conform to the shape of the stomach.

2. The intragastric balloon of claim 1 , wherein the fluid volume is between about 300 ml and about 700 ml.

3. The intragastric balloon of claim 2 , wherein the shell at the distal region has a greater thickness than the shell at the proximal region to prevent migration of the balloon out of the stomach.

4. The intragastric balloon of claim 2 , wherein the body includes a plurality of latitudinal ridges.

5. The intragastric balloon of claim 2 , wherein the body includes a plurality of longitudinal ridges.

6. The intragastric balloon of claim 2 , wherein the body includes a plurality of spaced pits.

7. The intragastric balloon of claim 1 , wherein the body has a plurality of regions including a proximal region and a distal region, and an outer wall of the shell of the body tapers from the proximal region to the distal region.

8. An intragastric balloon configured to be implanted transorally into a patient's stomach to treat obesity, the intragastric balloon comprising:

an inflatable, closed, hollow, non-spherical body including a body shell, the body having a volume between about 300 mls and about 700 mls, which volume is substantially the same both before and after inflation of the body with a fluid, the fluid occupying less than the volume of the body,

wherein the body shell is made of a compliant material and is permitted to be compressed into a substantially linear transoral delivery configuration, and that will resist degradation over a period of at least six months within the stomach,

wherein the body has a single closed Internal chamber in which the fluid can flow freely, the inflatable body being under-inflated to conform to the shape of the stomach,

wherein the body has a proximal region and a distal region, the proximal region larger than the distal region, the proximal region for inducing satiety by exerting a pressure on the stomach, and a smaller distal region for anchoring the balloon within the stomach,

wherein the shell at one of the proximal region and the distal region is thicker than the body wall at the other of the proximal region and the distal region.

9. The intragastric balloon of claim 8 , wherein the shell of the distal region is thicker than the shell at the proximal region to prevent migration of the balloon out of the stomach.

10. The intragastric balloon of claim 8 , wherein the body tapers from the proximal region to the distal region.

11. The intragastric balloon of claim 8 , wherein the body is substantially conical in shape.

12. The intragastric balloon of claim 8 , wherein the shell includes a plurality of circumferential grooves.

13. The intragastric balloon of claim 8 , wherein the shell includes a plurality of latitudinal ridges.

14. The intragastric balloon of claim 8 , wherein the shell includes a plurality of longitudinal ridges.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2023
From: APOLLO ENDOSURGERY, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 066128/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2023
From: APOLLO ENDOSURGERY US, INC.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 066128/0655 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 5, 2023
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; LPATH THERAPEUTICS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 063264/0046 →
RELEASE OF SECURITY INTEREST Recorded Dec 30, 2021
From: SLR INVESTMENT CORP. (F/K/A SOLAR CAPITAL LTD.)
To: APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; APOLLO ENDOSURGERY, INC.; LPATH THERAPEUTICS INC.
Reel/Frame 058599/0297 →
SECURITY INTEREST Recorded Dec 23, 2021
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC. (F/K/A LPATH, INC.)
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058980/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 15, 2019
From: APOLLO ENDOSURGERY US, INC.
To: SOLAR CAPITAL LTD., AS COLLATERAL AGENT
Reel/Frame 048885/0687 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 18, 2019
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: APOLLO ENDOSURGERY US, INC. (F/K/A APOLLO ENDOSURGERY, INC.)
Reel/Frame 048622/0328 →
CHANGE OF NAME Recorded Mar 27, 2017
From: APOLLO ENDOSURGERY, INC.
To: APOLLO ENDOSURGERY US, INC.
Reel/Frame 042106/0912 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 30, 2016
From: APOLLO ENDOSURGERY US, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 041224/0821 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2015
From: ALLERGAN, INC.
To: APOLLO ENDOSURGERY, INC
Reel/Frame 035358/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2015
From: SCHWAB, JUSTIN J.; DOMINGUEZ, ZACHARY P.; RAVEN, JOSEPH; BABKES, MITCHELL H.; MUDD, CHRISTOPHER S.; BERTOLOTE, TIAGO
To: ALLERGAN, INC.
Reel/Frame 035345/0729 →